Ninjurin-1 modulation and uses thereof
US8703711B2 · kind B2 · utility
2Cited by
7References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 8, 2010 |
| Grant date | Apr 22, 2014 |
| Priority date | — |
| Expiry date | Sep 18, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/143333
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods, uses, agents and compositions useful for the prevention, treatment and/or diagnosis of neuroinflammatory conditions such as multiple sclerosis and spinal cord injury based on the modulation of nerve injury-induced protein-1 (Ninjurin-1) are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.